10x Genomics Inc (NAS:TXG)
$ 24.34 -0.49 (-1.97%) Market Cap: 2.91 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.05 GF Score: 75/100

Q2 2021 10X Genomics Inc Earnings Call Transcript

Aug 04, 2021 / 08:30PM GMT
Release Date Price: $184.82 (+3.51%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the 10x Genomics Second Quarter 2021 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Eric Jaschke, Director of Investor Relations and Strategic Finance. Thank you, sir. Please go ahead.

Eric Jaschke

Thank you. Earlier today, 10x Genomics released financial results for the second quarter ended June 30, 2021. If you have not received this news release or if you'd like to be added to the company's distribution list, please send an e-mail to [email protected]. An archived webcast of this call will be available on the Investor tab of the company's website, 10xgenomics.com, for at least 45 days following this call.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot